DX4-13853-95253
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 284 / NC
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-24
Dose 1 — Pfizer-BioNTech
-
2021-02-14
Dose 2 — Pfizer-BioNTech
-
2021-03-04
Registered in v-safe
-
2021-03-04
Survey response — day 14, dose 2MedDRA: Herpes zoster — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: ShinglesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-13
Call successfulParticipant prefers to complete VAERS report online
- 2021-08-17
- 2022-02-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-24 | Pfizer-BioNTech | |
| 2 | 2021-02-14 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 5 — day 14, dose 2
Symptoms: Shingles
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Herpes zoster | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release